Code of Conduct Session Reinforces Ethical Standards Among Clinical Research Students at SRHU

Published on: August 2, 2024

On 2nd August 2024, the Department of Clinical Research at the Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, conducted an important session on the Code of Conduct for eleven clinical research students. The session aimed to highlight the significance of maintaining ethical behavior, respect, and accountability within the college community to create a safe and supportive environment for academic and social growth.

During the session, students were introduced to the purpose and scope of the Code of Conduct, which governs their behavior on campus, during college-sponsored events, and in all interactions related to the university. The facilitator emphasized key principles such as honesty, fairness, respect for others, and responsibility for one’s actions. Students were made aware of the rules they must follow and the consequences of actions like bullying, discrimination, and violence, which are strictly prohibited.

The interactive session concluded with a Q&A, ensuring that all participants clearly understood the guidelines and knew where to seek support if needed. Overall, the session successfully reinforced the importance of ethical standards and professional conduct, encouraging students to foster a culture of integrity and accountability that will benefit their academic journey and future careers.

Admissions Form

Admission Open For 2025

×

International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.